Nuclear Medicine: Page 111

Prostate radiotracer may benefit breast cancer imaging

By Wayne Forrest

A radiotracer recently cleared for PET imaging of recurrent prostate cancer may have similar efficacy for certain forms of breast cancer, according to a study presented at last week's Society of Nuclear Medicine and Molecular Imaging meeting.

June 23, 2016

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

June 21, 2016

Shine lands Chinese contract

By AuntMinnie.com staff writers

Shine Medical Technologies has won a contract to provide molybdenum-99 to Chinese radiopharmaceutical provider HTA.

June 20, 2016

Navidea touts Lymphoseek research

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals is directing attention to three studies involving its Lymphoseek radiopharmaceutical presented at last week's Society of Nuclear Medicine and Molecular Imaging meeting in San Diego.

June 19, 2016

Cell>Point signs licensing deal in China

By AuntMinnie.com staff writers

Biotechnology firm Cell>Point has inked a licensing deal with U.S. and China consortium United Eastern Pharmaceutical for its Oncardia radiopharmaceutical in China, Hong Kong, and Macau.

June 16, 2016

SNMMI: Optical-gamma imaging hybrid shows promise

By AuntMinnie.com staff writers

A work-in-progress hybrid optical-gamma imaging system can provide a visual representation of molecular data in the same frame as optical images of surface anatomy such as the skin and eyes, according to research presented at this week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in San Diego.

June 14, 2016

Sofie, PerkinElmer continue PET partnership

By AuntMinnie.com staff writers

Molecular imaging developer Sofie Biosciences and life sciences firm PerkinElmer have inked a multiyear extension of their existing partnership to develop preclinical in vivo imaging tools for PET.

June 14, 2016

SNMMI: FDG-PET predicts breast cancer outcomes

By Wayne Forrest

SAN DIEGO - FDG-PET is a considerably better predictor of treatment response and outcome than fluoride-PET for breast cancer patients with metastatic bone lesions, concluded researchers on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.

June 14, 2016

Novel PET combination awarded SNMMI Image of the Year

By Wayne Forrest

SAN DIEGO - German researchers have received this year's Image of the Year award from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for the use of three different radiotracers with PET to measure amyloid plaques, tau tangles, and metabolic activity in the brains of living Alzheimer's patients.

June 14, 2016

SNMMI coverage | Cutting dose in low-dose CT | Enterprise imaging

By Erik L. Ridley

June 13, 2016

SNMMI: FDG-PET can monitor immunotherapy for NSCLC

By AuntMinnie.com staff writers

FDG-PET can be used to monitor and predict outcomes from immunotherapy treatment of non-small cell lung cancer (NSCLC), according to research presented this week at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in San Diego.

June 13, 2016

Dilon highlights molecular breast tomo device at SNMMI

By AuntMinnie.com staff writers

Molecular breast imaging developer Dilon Diagnostics is highlighting new molecular breast tomosynthesis technology at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in San Diego.

June 13, 2016

Previous Page

Page 111 of 440

Next Page